Saturday, July 19, 2025

UK Sees Plateau in Long-Term Opioid Use Among Chronic Pain Sufferers

Similar articles

A comprehensive study spanning a decade highlights a stabilization in long-term opioid prescriptions among individuals grappling with chronic non-cancer pain in the UK. Despite heightened awareness of opioid-associated risks, dependency on these medications remains persistent.

Shifting Trends in Opioid Prescriptions

Analysis of data from over 2.8 million new opioid users between 2009 and 2019 reveals that approximately 11.4% transitioned to long-term opioid therapy within a year. Initial years saw a decline in long-term use, but a resurgence emerged post-2015, indicating fluctuating prescribing patterns influenced by policy changes and clinical practices.

Subscribe to our newsletter

Challenges in Reducing Dependence

The rate at which patients discontinued long-term opioid therapy decreased after 2015, suggesting that tapering off opioids has become more challenging. This trend underscores the limited availability of alternative treatments and the accessibility issues surrounding non-pharmacological pain management options.

Key inferences drawn from the study include:

  • The initial decline in long-term opioid use was likely impacted by stricter prescribing guidelines introduced before 2015.
  • The increase in long-term use post-2015 may reflect gaps in alternative pain management strategies.
  • Stable discontinuation rates prior to 2015 suggest consistent challenges in helping patients reduce opioid dependence.
  • Decreased discontinuation rates after 2015 highlight potential barriers in effective opioid tapering protocols.

The persistence of long-term opioid use despite known risks points to a critical need for expanding access to diverse treatment modalities. Enhancing the availability and affordability of non-opioid therapies, alongside robust support systems for patients attempting to reduce opioid use, could mitigate the reliance on these medications. Healthcare providers must prioritize integrated pain management approaches and address the systemic barriers that hinder the transition away from long-term opioid therapy.

Source


This article has been prepared with the assistance of AI and reviewed by an editor. For more details, please refer to our Terms and Conditions. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author.

Latest article